Evgeny Zaytsev

CIK: 0001674797

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CALC

CalciMedica, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

CALC
CalciMedica, Inc.
Oct 1, 2026
Award(A)
Director Stock Option (Right to Buy)
Direct
20K shares-
CALC
CalciMedica, Inc.
Aug 19, 2026
Award(A)
Warrant
Indirect
1.5M shares-
CALC
CalciMedica, Inc.
Aug 19, 2026
Award(A)
Warrant
Indirect
1.5M shares-
CALC
CalciMedica, Inc.
Aug 19, 2026
Award(A)
Director Stock Option (Right to Buy)
Direct
10K shares-
CALC
CalciMedica, Inc.
Jul 2, 2026
Award(A)
Director Stock Option (Right to Buy)
Direct
20K shares-

		Type	Shares	Price		Ownership
Oct 1, 2026	CALC CalciMedica, Inc.	Award(A) Director Stock Option (Right to Buy)	20,000	-	-	Direct
Aug 19, 2026	CALC CalciMedica, Inc.	Award(A) Warrant	1,450,267	-	-	Indirect
Aug 19, 2026	CALC CalciMedica, Inc.	Award(A) Warrant	1,450,267	-	-	Indirect
Aug 19, 2026	CALC CalciMedica, Inc.	Award(A) Director Stock Option (Right to Buy)	10,000	-	-	Direct
Jul 2, 2026	CALC CalciMedica, Inc.	Award(A) Director Stock Option (Right to Buy)	20,000	-	-	Direct

1-5 of 5 transactions

About Zaytsev Evgeny

Zaytsev Evgeny (SEC CIK 0001674797) files insider reports with the SEC as Director of CalciMedica, Inc. (CALC).

Signal8 holds 4 ownership filings by Zaytsev Evgeny (1 Form 3, 3 Form 4), filed between Jul 7, 2026 and Oct 5, 2026. Those filings report 5 transactions, from Jul 2, 2026 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Zaytsev Evgeny's filings is in LA JOLLA, CA.

Recent filings by Zaytsev Evgeny

Oct 1, 2026: Grant or award of CALC derivative securities (Form 4, code A).
Aug 19, 2026: Grants or awards of CALC derivative securities (3 lines, Form 4, code A).
Jul 2, 2026: Grant or award of CALC derivative securities (Form 4, code A).

Other insiders filing for CalciMedica, Inc. (CALC)

Glicklich Alan, Director
Guerard Frederic, Director
Shaw Allan, Director
WILSON ROBERT N, Director
Hebbar Sudarshan, Chief Medical Officer
Stauderman Kenneth A., Chief Scientific Officer

How to read Form 4 transaction codes